Text Size

Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy

This study is not yet open for participant recruitment.
Verified March 2011 by Rambam Health Care Campus
Sponsor:
Information provided by (Responsible Party):
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT01562067
First received: March 21, 2012
Last updated: March 22, 2012
Last verified: March 2011
History of Changes
  Purpose

Cervical tumors are characterized by vascular changes (in terms of quantity, volume and Flows) in the tumor. Due to a good access to the cervix through the vagina, these parameters can be assessed using a three dimensional supersonic. Sonographic characteristics of tumor indices measures before and after oncological treatments may shed light on the patient's prognosis.


Condition Intervention
Cancer
 Device: ultrasound examination

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:
  • Sonographic characteristics of cervical tumors [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    Sonographic characteristics of cervical tumors indices measures before and after oncological treatments may shed light on the patient's prognosis.


Biospecimen Retention:   Samples Without DNA

pap smear


Estimated Enrollment: 40
Study Start Date: March 2012
Estimated Study Completion Date: April 2014
Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: ultrasound examination
    ultrasound and doppler studies to evaluate size and vascularity of tumor during radiotherapy
    Other Name: no other name
Detailed Description:

no editional information. see above

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

women with cervical cancer during radiotherapy

Criteria

Inclusion Criteria:

  • Cervical cancer patients intended to undergo chemotherapy or radiation, or both

Exclusion Criteria:

  • no exclusions
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01562067

Locations
Israel
Rambam Medical Center Not yet recruiting
Haifa, Israel, 30196
Contact: amnon amit, md     97248543872 ext 3872     a_amit@rambam.health.gov.il    
Principal Investigator: amnon amit, md            
Sponsors and Collaborators
Rambam Health Care Campus
Investigators
Principal Investigator: amnon amit, md Rambam Health Care Campus
  More Information

No publications provided

Responsible Party: Rambam Health Care Campus
ClinicalTrials.gov Identifier: NCT01562067     History of Changes
Other Study ID Numbers: 125-11CTIL
Study First Received: March 21, 2012
Last Updated: March 22, 2012
Health Authority: Israel: Ministry of Health

Keywords provided by Rambam Health Care Campus:
Cervical tumors,vascular changes,Sonographic characteristics

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
 Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female

ClinicalTrials.gov processed this record on May 23, 2013